Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Steinberg

Showing results (561-570 of 620) with videos related to

Pageof 62
Sort By:
Cell Discovery|March 14, 2024
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Science Translational Medicine|September 4, 2020
SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic controlMagdalene K Montgomery, Jacqueline Bayliss, Camille Devereux, et al.
Diabetes|September 11, 2012
Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesitySebastian Beck Jorgensen, Hayley M O'Neill, Lykke Sylow, et al.
The Biochemical Journal|March 6, 2015
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivityRebecca J Ford, Morgan D Fullerton, Stephen L Pinkosky, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinomaEvangelia E Tsakiridis, Elham Ahmadi, Jaya Gautam, et al.
Cell Discovery|July 13, 2017
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Cell Metabolism|July 14, 2016
Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue FunctionEmilio P Mottillo, Eric M Desjardins, Justin D Crane, et al.
Nature Medicine|July 25, 2018
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivoAnila K Madiraju, Yang Qiu, Rachel J Perry, et al.
Molecular Oncology|August 16, 2023
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1αOlga-Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali, et al.
Nature Medicine|February 9, 2019
Author Correction: Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivoAnila K Madiraju, Yang Qiu, Rachel J Perry, et al.
Pageof 62

Showing results (561-570 of 620) with videos related to

Sort By:
Pageof 62
Cell Discovery|March 14, 2024
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Science Translational Medicine|September 4, 2020
SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic controlMagdalene K Montgomery, Jacqueline Bayliss, Camille Devereux, et al.
Diabetes|September 11, 2012
Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesitySebastian Beck Jorgensen, Hayley M O'Neill, Lykke Sylow, et al.
The Biochemical Journal|March 6, 2015
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivityRebecca J Ford, Morgan D Fullerton, Stephen L Pinkosky, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinomaEvangelia E Tsakiridis, Elham Ahmadi, Jaya Gautam, et al.
Cell Discovery|July 13, 2017
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Cell Metabolism|July 14, 2016
Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue FunctionEmilio P Mottillo, Eric M Desjardins, Justin D Crane, et al.
Nature Medicine|July 25, 2018
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivoAnila K Madiraju, Yang Qiu, Rachel J Perry, et al.
Molecular Oncology|August 16, 2023
Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1αOlga-Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali, et al.
Nature Medicine|February 9, 2019
Author Correction: Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivoAnila K Madiraju, Yang Qiu, Rachel J Perry, et al.
Pageof 62